Use of propranolol for treatment of infantile haemangiomas in an outpatient setting

Journal of Paediatrics and Child Health

Volumn 48, Issue 10, 2012, Pages 902-906

  Phillips, Roderic J ^a   Penington, Anthony J ^a   Bekhor, Philip S ^a   Crock, Catherine M ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

haemangioma; haemangioma of infancy; PHACES syndrome; propranolol; vascular birthmark

Indexed keywords

PREDNISOLONE; PROPRANOLOL;

ANOREXIA; ARTICLE; CAPILLARY HEMANGIOMA; CHILD; DIARRHEA; DRUG DOSE INCREASE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROENTERITIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NEWBORN; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSED DYE LASER; RECURRENT DISEASE; SCHOOL CHILD; SLEEP DISORDER; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING; WALKING DIFFICULTY;

ADMINISTRATION, ORAL; AMBULATORY CARE; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FACIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROPRANOLOL; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84867897632     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2012.02521.x     Document Type: Article

References (11)

1. Drolet BA, Esterly NB, Frieden IJ,. Hemangiomas in children. N. Engl. J. Med. 1999; 341: 173-81.
2. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A,. Propranolol for severe hemangiomas of infancy. N. Engl. J. Med. 2008; 358: 2649-51.
3. Sans V, Dumas de la Roque E, Berge J, et al,. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124: e423.
4. Missoi TG, Lueder GT, Gilbertson K, Bayliss SJ,. Oral propranolol for treatment of periocular infantile hemangiomas. Arch. Ophthalmol. 2011; 129: 899-903.
5. Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN,. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int. J. Pediatr. Otorhinolaryngol. 2009; 73: 1168-72.
6. Arneja JS, Pappas PN, Shwayder TA, et al,. Management of complicated facial hemangiomas with beta-blocker (propranolol) therapy. Plast. Reconstr. Surg. 2010; 126: 889-95.
7. Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT,. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope 2010; 120: 676-81.
8. Qin ZP, Liu XJ, Li KL, Zhou Q, Yang XJ, Zheng JW,. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety]. Zhonghua Yi Xue Za Zhi 2009; 89: 3130-4 (in Chinese).
9. Hogeling M, Adams S, Wargon O,. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics 2011; 128: e259-66.
10. WHO Multicentre Growth Reference Study Group, de Onis M,. WHO Motor Development Study: windows of achievement for six gross motor development milestones. Acta Paediatr. 2006; 95: 86-95.
11. Greenhill NB, Deacon GB, Phillips RJ,. Giving propranolol to infants with hemangiomas-solubility in water. J. Paediatr. Child Health 2011; 47: 484-5.